Brain Power Spectral Density Under Propofol (PROBRAIN)
Brain Power Spectral Density Under Propofol and Its Association With Cerebral Fragility, an Objective Means to Estimate the Probability of Presenting Burst Suppression
Sponsor: INSERM UMR-942, Paris, France
A observational or N/A phase clinical study on Interventional and Orthopedic Surgery, this trial is completed. The trial is conducted by INSERM UMR-942, Paris, France and has accumulated 4 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Apr 2019 — Jan 2021 [monthly]
Completed
First recorded
Jan 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- INSERM UMR-942, Paris, France
- Joaquim MATEO
- M3DISIM
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.